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Annotation. Systemic autoimmune rheumatic diseases are characterized by high mortality in all regions of the globe, and the 
number of such patients is growing everywhere. Vascular damage (angiopathy, vasopathy, vasculopathy) is one of the main 
manifestations of systemic lupus erythematosus (SLE), systemic scleroderma (SSD), rheumatoid arthritis (RA) and ankylos-
ing spondylitis (AS). The aim of the study was to improve the quality of diagnostics, to establish new links in pathogenesis and 
to identify prognostic criteria for the clinical course of vascular lesion in systemic autoimmune rheumatic diseases. Systemic 
angiopathy develops in 88% of the number of patients with SSD, 85% with AS, 84% with SLE and 61% with RA, accord-
ing to laboratory and instrumental methods of research in patients with different nosological forms of systemic autoimmune 
rheumatic diseases, there are features of vascular lesions that depend on the degree activity of the pathological process. 
Further clarification of clinical, laboratory and instrumental features of vascular lesions in systemic autoimmune rheumatic 
diseases will improve the quality of early diagnosis of the pathological process, develop criteria predicting the clinical course 
of the disease.
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Introduction. The systemic autoimmune rheumatic diseases 
(SARD) group includes systemic lupus erythematosus (SLE), systemic 
scleroderma (SSD), rheumatoid arthritis (RA) and ankylosing spondylitis 
(AS), which are characterized by increase arterial rigidity with signs of 
generalized angiopathy [1,2]. SARD are characterized by high mortality 
in all regions of the globe, and the number of such patients is increasing 
everywhere [3]. Among all diseases of the rheumatological profile, 
the share of SLE and RA is  by 3% of cases, SSD and AS - by 2% 
respectively [4].
Vascular damage (angiopathy, vasopathy, vasculopathy) is one 
of the main manifestations of SLE, SSD, RA and AS, which according 
to the International Chapel-Hill classification are characterized as 
"vasculitis associated with a systemic disease" [5, 6]. Angiopathy in 
the presence of SARD can involve vessels of the most diverse caliber 
- from the lesions of capillaries and arterioles (much more often) to 
the aorta, and the clinical course and pathogenesis of such vascular 
changes have not been studied sufficiently [7-10].
The aim of the study: to improve the quality of diagnostics, to 
establish new links in the pathogenesis and to identify prognostic 
criteria for the course of vascular lesions in SARD.
Material and methods. 379 patients with SARD were monitored, 
including 112 patients with SLE, 57 – with SRS, 131 - with RA, and 
79 - with AS. In the first group, the ratio of men and women was 1: 9, 
in the second group - 1: 8, in the third group - 1: 2, in the fourth - 19: 1, 
minimal, moderate and high degree of disease activity - 1: 2: 1, 2: 2: 1, 
1: 2: 1, 1: 1: 1 respectively, the average age of the examined patients 
was 35,7 ± 1,02 years, 41,5 ± 1,67 years, 45,7 ± 1,02 years, 38,3 ± 1,28 
years, and the duration of clinical manifestation was 11,6 ± 0,78 years, 
11,0 ± 0,95 years, 9,4 ± 0,68 years and 11,3 ± 0,82 years. The subacute 
course of SLE was found in 14% of cases, and the ratio of I, II, III and 
IV stages of chronic kidney disease was 20: 2: 2: 1, the limited form of 
SSD occurred in 47% of cases, diffuse - in 30%, I, II , III and IV stages 
of RA were diagnosed in 8%, 40%, 34% and 19% of the number of 
patients, and the average arthritis activity was 4,5 ± 0,10 r.u, the ratio of 
slow to fast-progressive AS 4: 1, with bilateral sakroileitis found in 73% 
of cases, and enthesites in 10%.
Patients underwent echocardiography (Acuson-Aspen-Siemens, 
Germany and HD-11-XE-Philips, the Netherlands), sonography of 
vessels and internal organs (Envisor-Philips (Netherlands), ultrasound 
dopplerography of vessels (Aplia-XG-Toshiba, Japan), conjunctival 
biomycroscopy ("Haag-Streit-Bern-900", Switzerland) was used to 
determine the integral clinical and instrumental indices of vascular 
pathology (Ω, Ψ) . The content of C-reactive protein (CRP) and rheumatoid 
factor (RF) in blood serum were studied with the analyzer "Olympus-
AU-640" (“Japan”), concentration of anti-deoxyribonucleic acid (aDNA), 
cardiolipin (aCL), citrulline cyclic peptide (aCCP), endothelial vascular 
growth factor (VEGF), endothelin-1 (ET1), thromboxane-A2 (TxA2), 
prostacyclin (PgI2), cyclic guanosine monophosphate (CGMP) was 
studied with reader PR2100 Sanofi diagnostic pasteur, France), - levels 
of antinuclear factor (ANF) and topoisomerase antibodies (aScl70) 
were studied  with  imunoblot method(Euroline-Euroimmun, Germany).
Statistical processing of the obtained results of the research 
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was carried out with the help of computer variational, correlation, 
nonparametric, ANOVA and multivariate ANOVA / MANOVA variance 
analysis (Microsoft Excel and Statistica-Stat-Soft, USA). The mean 
values, their standard deviations and errors, the Pearson correlation 
parametric coefficients and the nonparametric Kendall coefficients, the 
Brown-Forsythe and Wilcoxon-Rao dispersion criteria, the Student-
McNamara-Fisher differences, and the reliability of the statistical 
indices were estimated. The critical level of significance in this study 
when testing statistical hypotheses was assumed to be 0.05.
Results. Patients with angiopathy were included in the main group 
of examinees, while the remaining patients were in the control group. 
The frequency of separate signs of angiopathy in patients with SARD 
are presented in the table.
The systemic nature of angiopathy develops in 84% of the number 
of patients with SLE, which is associated with the overall severity of the 
disease and the state of the autonomic nervous system, it is determined 
by the degree of activity of the pathological process, by the presence 
and levels of ANF and aCL in blood, by involving capillaries, arterioles, 
aorta and carotid arteries,  by the development of antiphospholipid 
syndrome, pulmonary hypertension, skin lesions, its appendages, 
mucous membranes, kidney, central and peripheral nervous system. 
And a status of conjunctiva vessels in the biomicroscopy may be an 
integral diagnostic criterion.
Table. The frequency of diiferent angiopathy signs in patients 
with SARD (%)
Manifest lesion of the vessels is observed in 88% of the number of 
patients with SSD, the clinical and instrumental features of which are closely 
related to the degree of activity and duration of the disease, the nature of 
the "vegetative passport" (vagotonic or sympathotonic type), seropositivity 
for aScl, ANF, aDNA and aCL, but angiopathy is accompanied by changes 
in vasodilation, increased pulmonary pressure and vascular resistance, 
while the integral parameters of Ω and Ψ affect the severity of scleroderma 
pneumopathy and nephropathy, and the values of aScl and ANF, along 
with the level of endothelial dysfunction of blood vessels, participate in 
pathogenetic constructs of vasculopathy.
Systemic angiopathy is observed in 61% of the RA patients, more 
often in cases of high visceral activity with the presence of osteoporosis, 
the development of skin vasculitis and peripheral vasoneuropathy 
closely related to the level of aCCP in serum, which, along with the 
CRP concentration, has a negative prognostic significance concerning 
vascular pathology, and the appearance of digital arteritis is determined 
by the activity of the joint syndrome, glomerulonephritis - high level of 
aCCP in blood, and the presence of angiopathy reflects the increase of 
pressure in a lesser circulation.
Angiopathy is observed in 85% of the patients with AS, the 
development of which is directly related to the degree of activity of 
the pathological process and to RF seropositivity, at the same time 
cutaneous vasculitis depends on the age of the patients; and uveitis, 
scleritis, Raynaud's syndrome, central and peripheral nervous system 
damage - on the features of the course of the joint syndrome; the integral 
indices of Ω and Ψ reliably correlate with RF and CRP, and vascular 
lesions occurs with an increase in the values of pulmonary pressure 
and vascular resistance, in the genesis of which CRP participates, that 
have prognostic significance.
Endothelial dysfunction of the vessels develops in 53% of the 
patients with AS, which in the presence of vascular pathology is 
accompanied by a large increase in the concentration of cGMP in the 
blood and a decrease in PgI2, which is associated with the duration of 
the disease, the degree of activity of the pathological process, peripheral 
nervous system lesion, the severity of spondylopathy and sacroiliitis, at 
the same time violations of endothelial vascular dysfunction involved in 
the pathogenetic constructs of enthesopathies, tendovaginitis, uveitis 
and scleritis, determine the rate of the joint syndrome progression and 
the integral severity of angiopathy.
Endothelial dysfunction of vessels in the form of an imbalance of 
vasoconstrictors VEGF, ET1, TxA2 and  vasodilator PgI2 occurs in 35% 
of RA patients with renal damage and in 39% of SLE patients, which 
are closely related to the severity of clinical and instrumental signs of 
systemic angiopathy (with skin, mucous membranes and peripheral 
nervous system lesions, with parameters of biomicroscopy of the 
vessels of the conjunctiva and vasodilation of the brachial artery).
On the basis of the performing variational, correlation, regression 
and variance analysis, the criteria have a certain practical significance: 
1) prognosis negative criteria for the severe course of angiopathy in SLE
are serum level of aCL> 15 U/ml and in RA - the content of аССР > 40 
U/ml; 2) in patients with SSD, the values of the total vasal conjunctival 
index> 10 points refer to the unfavorable signs of the leukocytoclastic 
enanthema; 3) in cases of SSD and AS to the risk factors for pulmonary 
hypertension are concerned the positivity of the disease according to 
aScl70 and concentration in the blood CRP> 20 mg / l, respectively.
Conclusion. Systemic angiopathy develops in 88% of the number 
of patients with SSD, 85% -  with AS, 84% - with SLE and 61% - 
with RA, and according to laboratory and instrumental methods 
of research, there are features of vascular lesions in patients with 
different nosological forms of autoimmune rheumatic diseases, in the 
pathogenetic constructions of which immune and endothelial-vascular 
disorders are involved. Further clarification of the features of vascular 
lesions in SLE, SSD, RA and AS will contribute to improving the quality 
of early diagnosis of the pathological process, the development of 
predicting criteria the course of the disease.
Features 
of angiopathy
Nosoological form SARD
SLE 
(n=112)
SSD 
(n=57)
RA 
(n=131)
AS 
(n=79)
Vascular lesion
 of the skin 75,5 17,6 20,0 10,1
Capillaritis 
of hands and feet 11,7 8,8 12,5 1,3
Leukocytoclastic 
enanthema 13,8 7,0 - -
Heilit 7,5 - - 1,3
Uveitis 6,4 8,8 23,8 26,6
Raynaud's 
syndrome 30,9 89,5 18,8 13,9
Arterial 
hypertension 34,1 29,8 16,3 15,2
Pulmonary 
hypertension 20,2 24,6 21,3 51,9
Glomerulonephritis 83,0 19,3 26,3 25,3
Antiphospholipid 
syndrome 35,1 14,0 8,8 5,1
Encephalopathy 33,0 26,3 6,3 53,2
Peripheral 
vasoneuropathy 16,0 33,3 21,3 32,9
64
EUROPEAN ASSOCIATION OF PEDAGOGUES, PSYCHOLOGISTS AND MEDICS "SCIENCE"
M
edical sciences
Refferences.
1. Heijnen T, Wilmer A, Blockmans D, Henckaerts L. Outcome of patients with systemic diseases admitted to the medical
intensive care unit of a tertiary referral hospital: a single-centre retrospective study. Scand J Rheumatol 2016; 45 (2): 146-
50. doi: 10.3109/03009742.2015.1067329.
2. Ungprasert P, Srivali N, Kittanamongkolchai W. Ankylosing spondylitis and risk of venous thromboembolism: A systematic
review and meta-analysis. Lung India 2016; 33 (6): 642-5. doi: 10.3978/j.issn.2305-5839.
3. Ramos-Casals M, Brito-Zerón P, Kostov B, Sisó-Almirall A, Bosch X, Buss D, Trilla A, Stone JH, Khamashta MA,
Shoenfeld Y. Google-driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with 
systemic autoimmune diseases. Autoimmun Rev 2015; 14 (8): 670-9. doi: 10.1016/j.autrev.2015.03.008.
4. Yang Z, Ren Y, Liu D, Lin F, Liang Y. Prevalence of systemic autoimmune rheumatic diseases and clinical significance
of ANA profile: data from a tertiary hospital in Shanghai, China. APMIS 2016; 124 (9): 805-11. doi: 10.1111/apm.12564.
5. Anic B. New classification of vasculitis. Lijec Vjesn 2014; 136 (7-8): 226-8.
6. Sharma A, Dhooria A, Aggarwal A, Rathi M, Chandran V. Connective tissue disorder-associated vasculitis. Curr
Rheumatol Rep 2016; 18 (6): 31-41. doi: 10.1007/s11926-016-0584-x.
7. Dessertenne G, Canaud L, Marty-Ané C, Alric P. Saccular thoracoabdominal aneurysms in systemic lupus erythematosus. 
Ann Vasc Surg 2015; 29 (7): 14481-3. doi: 10.1016/j.avsg.2015.03.056.
8. Giannakakis S, Galyfos G, Stefanidis I, Kastrisios G, Maltezos C. Hybrid treatment of lower limb critical ischemia in a
patient with systemic lupus erythematosus. Ann Vasc Surg 2015; 29 (3): 5961-5. doi: 10.1016/j.avsg.2014.10.040.
9. Maldonado A, Blanzari JN, Asbert P, Albiero JA, Gobbi C, Albiero E, Alba P. Medium vessel vasculitis in systemic lupus
erythematosus. Rev Fac Cien Med Univ Nac Cordoba 2016; 73 (1): 50-2.
10. Wong U, Yfantis H, Xie G. Urticarial vasculitis-associated intestinal ischemia. Case Rep Gastrointest Med 2016; 20
(16): 8603679. doi: 10.1155/2016/8603679.
UDC 614.2
INFORMATION FACTORS OF INCREASING ADHERENCE 
OF PATIENTS TO CLINICAL EXAMINATION
Zhilyaeva T.P.
Researcher
Laboratory of modeling of management 
technologies Federal State Budget Scientific 
Institution "Scientific Re-search Institute of Complex 
Problems of Cardiovascular Diseases", 
Kemerovo, Russia
Sosnoviy bulvar, 6, Kemerovo, Russia, 650000
Strokolskaya I.L.
Researcher 
Laboratory of modeling of management technologies
Federal State Budget Scientific Institution "Scientific Re-
search Institute of Complex Problems of Cardiovascular 
Diseases", Kemerovo, Russia
Sosnoviy bulvar, 6, Kemerovo, Russia, 650000
Жиляева Т.П.
Научный сотрудник
Лаборатория моделирования управленческих 
технологий Федеральное государственное 
бюджетное научное учреждение 
«Научно-исследовательский институт 
комплексных проблем 
сердечно-сосудистых заболеваний», Кемерово, 
Россия Сосновый бульвар, 6, г. Кемерово, Россия, 
650000 
Строкольская И.Л.
Научный сотрудник
Лаборатория моделирования управленческих технологий
Федеральное государственное бюджетное научное 
учреждение
 «Научно-исследовательский институт 
комплексных проблем 
сердечно-сосудистых заболеваний», Кемерово, Россия
Сосновый бульвар, 6, г. Кемерово, Россия, 650000
Abstract. Forming the population's need for prevention is one of the main tasks of public health. The actual issue remains the 
study of ways to increase the awareness and attendance of the population of preventive measures. The introduction of mod-
ern information technologies makes it possible to increase the attendance of citizens for preventive measures. The authors 
analyze the means and methods of inviting the population for clinical examination and identified the features that should be 
taken into account when forming public awareness programs.
Keywords: prophylaxis, medical examination, information technologies.
Аннотация. Формирование у населения потребности к профилактике – это одна из основных задач общественного 
здравоохранения. Актуальным вопросом остается изучение способов повышения   информированности и 
